Cargando…

Successful treatment of a patient with refractory nephrotic syndrome with PCSK9 inhibitors: a case report

BACKGROUND: The proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitor evolocumab is a low-density lipoprotein (LDL)-lowering drug with a new mechanism, which is currently available in Japan. Here, for the first time, we report the successful use of the PCSK9 inhibitor in a patient with ref...

Descripción completa

Detalles Bibliográficos
Autores principales:	Awanami, Yuki, Fukuda, Makoto, Nonaka, Yasunori, Takashima, Tsuyoshi, Matsumoto, Keiichiro, Yamasaki, Masatora, Miyazono, Motoaki, Ikeda, Yuji
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2017
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5501341/ https://www.ncbi.nlm.nih.gov/pubmed/28683788 http://dx.doi.org/10.1186/s12882-017-0644-0

Ejemplares similares

A case of anti-neutrophil cytoplasmic antibody-associated vasculitis with anti-glomerular basement membrane antibodies that was successfully treated with mizoribine as a safe and effective remission maintenance therapy with prednisolone and plasma exchange
por: Ikeda, Yuki, et al.
Publicado: (2019)

Risks and Benefits of Sodium Polystyrene Sulfonate for Hyperkalemia in Patients on Maintenance Hemodialysis
por: Nakamura, Teruko, et al.
Publicado: (2018)

A one-sheath inverse method in vascular access intervention therapy for hemodialysis patients
por: Takashima, Tsuyoshi, et al.
Publicado: (2018)

Pseudohypercreatininemia after surgery for aortic dissection: a case report
por: Tasaki, Ayako, et al.
Publicado: (2023)

Effects of hydrogen-rich water in a rat model of polycystic kidney disease
por: Yamasaki, Masatora, et al.
Publicado: (2019)

A Comparison of the Long-Term Effects of Lanthanum Carbonate and Calcium Carbonate on the Course of Chronic Renal Failure in Rats with Adriamycin-Induced Nephropathy
por: Takashima, Tsuyoshi, et al.
Publicado: (2014)

Radial artery-second dorsal metacarpal vein arteriovenous fistula in the first interdigital space for hemodialysis: Utilization of the most peripheral site and autologous vein in the upper limb – A case report
por: Takashima, Tsuyoshi, et al.
Publicado: (2020)

Warfarin‐related nephropathy: A case report of a delayed renal function improvement
por: Nonaka, Eriko, et al.
Publicado: (2021)

A Report of an Adult Case of Tubulointerstitial Nephritis and Uveitis (TINU) Syndrome, with a Review of 102 Japanese Cases
por: Matsumoto, Keiichiro, et al.
Publicado: (2015)

Significance of Technetium-99m Human Serum Albumin Diethylenetriamine Pentaacetic Acid Scintigraphy in Patients with Nephrotic Syndrome
por: Takashima, Tsuyoshi, et al.
Publicado: (2015)

Efficacy and Safety of PCSK9 Inhibitors in Hypercholesterolemia Associated With Refractory Nephrotic Syndrome
por: Jatem, Elias, et al.
Publicado: (2020)

Perirenal Abscess in a Patient with Rheumatoid Arthritis
por: Fukuda, Makoto, et al.
Publicado: (2022)

Masked hyperthyroidism in a haemodialysis patient successfully treated by potassium iodide
por: Meyrier, A., et al.
Publicado: (2012)

Pre-existing chronic interstitial pneumonia is a poor prognostic factor of Goodpasture’s syndrome: a case report and review of the literature
por: Tashiro, Hiroki, et al.
Publicado: (2017)

Lipid Lowering Therapy and Circulating PCSK9 Concentration
por: Nozue, Tsuyoshi
Publicado: (2017)

Tocilizumab preserves renal function in rheumatoid arthritis with AA amyloidosis and end-stage kidney disease: Two case reports
por: Fukuda, Makoto, et al.
Publicado: (2021)

Feasibility of Short-Term Aggressive Lipid-Lowering Therapy with the PCSK9 Antibody in Acute Coronary Syndrome
por: Yamashita, Satoshi, et al.
Publicado: (2023)

Beneficial effect of LDL-apheresis in refractory nephrotic syndrome
por: Muso, Eri
Publicado: (2014)

A case of endocapillary glomerulonephritis associated with peripheral blood natural killer cell proliferation
por: Kishi, Tomoya, et al.
Publicado: (2011)

FOURIER & PCSK9 RNAi: Towards enhancing durability and efficacy of PCSK9 inhibitors
por: Hassan, Mohamed
Publicado: (2017)

The PCSK9 revolution and the potential of PCSK9-based therapies to reduce LDL-cholesterol
por: Seidah, Nabil G.
Publicado: (2017)

The Multifaceted Biology of PCSK9
por: Seidah, Nabil G, et al.
Publicado: (2021)

Successful treatment of peritoneal dialysis for two patients with refractory nephrotic syndrome and acute kidney injury: a case report
por: Yu, Le, et al.
Publicado: (2023)

Cyclosporine A for the treatment of refractory nephrotic syndrome with renal dysfunction
por: GAO, XIANG, et al.
Publicado: (2014)

Therapy with the Combination of Tolvaptan and Furosemide for Refractory Edema in Nephrotic Syndrome
por: Meena, Jitendra, et al.
Publicado: (2020)

Apheresis in Adult With Refractory Idiopathic Nephrotic Syndrome on Native Kidneys
por: Moret, Léa, et al.
Publicado: (2021)

Refractory giardiasis in a child with steroid-resistant nephrotic syndrome
por: Kalita, Jitu Mani, et al.
Publicado: (2023)

Eligibility, Clinical Outcomes, and Budget Impact of PCSK9 Inhibitor Adoption: The CANHEART PCSK9 Study
por: Ko, Dennis T., et al.
Publicado: (2018)

The effect of PCSK9 immunization on the hepatic level of microRNAs associated with the PCSK9/LDLR pathway
por: Ataei, Sarina, et al.
Publicado: (2023)

PCSK9 Antibodies for the Treatment of Hypercholesterolemia
por: Gouni-Berthold, Ioanna, et al.
Publicado: (2014)

PCSK9 and Atherosclerosis - Lipids and Beyond
por: Shapiro, Michael D., et al.
Publicado: (2017)

An Update on the Role of PCSK9 in Atherosclerosis
por: Yurtseven, Ece, et al.
Publicado: (2020)

Autocrine effects of PCSK9 on cardiomyocytes
por: Wolf, Annemarie, et al.
Publicado: (2020)

Naturally Occurring PCSK9 Inhibitors
por: Adorni, Maria Pia, et al.
Publicado: (2020)

PCSK9 Monoclonal Antibodies: An Overview
por: Kaddoura, Rasha, et al.
Publicado: (2020)

Pleiotropic Effects of PCSK-9 Inhibitors
por: Basiak, Marcin, et al.
Publicado: (2021)

Phage display for targeting PCSK9
por: Ferri, Nicola
Publicado: (2021)

Insight into the Evolving Role of PCSK9
por: Maligłówka, Mateusz, et al.
Publicado: (2022)

Gene Therapy Targeting PCSK9
por: Katzmann, Julius L., et al.
Publicado: (2022)

PCSK9 as an Atherothrombotic Risk Factor
por: Sotler, Tadeja, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_pasor902oa8b24u9bqmesvdaof